In capitalism, a good will and intention to advance technology for benefiting humankind isn’t enough. In capitalism, advancing technology must be commercially successful to make it viable and continuously doable.
A technology that cannot and does not succeed in the marketplace has no place to be.
I want to advance biotechnology for benefiting people, particularly in human longevity biotech, and human-body disease, disability, and damage cure biotech. Without commercial success, no technology, including and especially biotechnology, has a place and reason to be.
A quick advertisement before I continue on this topic. I’m seeking accredited investors in my startup with an SEC Regulation D Rule 506(c) offering. If you’re interested in investing in my startup as an accredited investor, voice call me or message me on Instagram to discuss investing in Robocentric. Visit Robocentric.com/Investors for more info on investing in Robocentric; visit Robocentric.com/About to learn more about Robocentric. Now, back to the main content.
I must be concerned about the commercial side of biotechnology, as well as the scientific and technical sides of developing biotechnologies.
I aim to build the Robocentric biotech division to have a number of highly financially successful biotech product categories, namely the following.
Biotech research hardware and software equipment product categories
Medical biotech product categories
Food production biotech product categories
Waste biomatter processing and recycling biotech product categories
Industrial and consumer biomatter product categories
Human and nonhuman neurotech product categories
Biotech research hardware and software equipment product categories include, but are not limited to, Robocentric sensor biotech products, Robocentric scanner biotech products, Robocentric genomics biotech products, and Robocentric proteomics biotech products; robotic fully-automated mass light microscopy system; robotic fully-automated mass electron microscopy system; ultralow-cost cell and cell-component staining biotechnologies; ultralow-cost 3D microscopic biomatter scanner; ultralow-cost protein mass spectrometer; ultralow-cost whole genome sequencer; computational biomatter modeler and designer; biomatter synthesizer; biomatter sensor.
Medical biotech product categories include, but are not limited to, biosynthetic antimicrobial peptides for medical uses such as before, during, and after a surgery; medicine bacteria biotech, such as antibiotics production biotech (e.g. antibiotic producing synthetic bacteria); antiviral drugs design and manufacturing biotech; antibiotic and antibacterial drug design and manufacturing biotech; antibacterial soaps design and manufacturing biotech; infection treatment drug design and manufacturing biotech; farm animal antibiotic design and manufacturing biotech; antifungal drugs design and manufacturing biotech; medical biotech for humans, food plants and animals (antibacterial, antiviral, antifungal drugs, faster wound cure and damage recovery by accelerating cell growth and division with telomere lengthening, human body damage cure and recovery)
Food production biotech product categories include, but are not limited to, human-food plant and animal growth accelerator biotech (for producing higher quality foods at cheaper prices in shorter time); food processing biotech (food bacteria, enzymes, etc.)
Industrial and consumer biomatter product categories include, but are not limited to, manufacturing, construction, and biomaterials-processing industrial biomatter product categories; water-resistant biosynthetic glue; industrial biomatter processing enzymes (such as on cattle biomatter), bacteria, with enzyme synthesis biotech and bacteria genomics, design, genetic engineering, and synthesis biotech; manufacturing and construction plant and animal growth accelerator biotech (such as genetic engineering with faster cell growth and division); repeat-consumable biomatter design and production biotech (for bioactive cleaners, soaps, detergents—biosynthetic enzymes for better cleaning marketed under a consumer brand); bioprocessed manufacturing, construction, and craft biomatter; brand-new lifeforms such as greenhouse gas trapping and converting plants.
Generally, beneficial bioactive ingredients design and manufacturing and marketing focus in medical, human-food, and industrial and consumer biomatter production Robocentric Biotech business and productization effort for repeat-consumable synthetic biomatter production and marketing.
Human and nonhuman neurotech product categories include, but are not limited to, destructive human and nonhuman brain structure measurement device; non-destructive human and nonhuman brain structure measurement device (for medical screening, for example); invasive human and nonhuman brain activities measurement device; non-invasive human and nonhuman brain activities measurement device.
You can invest in my startup company with as little as US$100, for supporting advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech. Visit Robocentric.com/Investors to invest in my startup.
My books on advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech are available at Robocentric.com/Checkout, Amazon, Apple Books, Spotify, Google Play Store, and other online audiobook retailers.
I am Allen Young; I’m an Asian-American man who focuses on advancing AI, robotics, human longevity biotech, and nuclear-fusion powered outer space tech.